Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice

Microglial healing peptide 1, “MHP1”, is a newly developed synthetic peptide composed of the DE and a part of the EF loop of the receptor activator of nuclear factor-кB (NFκB) ligand (RANKL). Our previous report demonstrated that MHP1 significantly inhibits Toll-like receptor (TLR) 2- and 4-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimamura, Munehisa, Nakagami, Hironori, Shimizu, Hideo, Wakayama, Kouji, Kawano, Tomohiro, Ikeda, Yuka, Hayashi, Hiroki, Yoshida, Shota, Mochizuki, Hideki, Morishita, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091369/
https://www.ncbi.nlm.nih.gov/pubmed/30151382
http://dx.doi.org/10.1155/2018/4637084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091369/
https://www.ncbi.nlm.nih.gov/pubmed/30151382
http://dx.doi.org/10.1155/2018/4637084

Ejemplares similares